90
Participants
Start Date
February 29, 2008
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
EVT 302, 10 mg
2 X EVT 302, 5 mg tablets
placebo
2 X placebo tablets to match EVT 302 5 mg
Nicotine replacement therapy (NRT)
NRT patch containing 21 mg of nicotine
NRT placebo
Medically inert plaster cut to match the NRT plaster
PAREXEL International GmbH, Clinical Pharmacology Research Unit, Berlin
Lead Sponsor
Evotec Neurosciences GmbH
INDUSTRY